Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.25
+0.08 (1.12%)
At close: Mar 4, 2026, 4:00 PM EST
7.14
-0.11 (-1.52%)
After-hours: Mar 4, 2026, 6:55 PM EST
Replimune Group Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Selling, General & Admin | 103.96 | 73.06 | 60.72 | 50.97 | 39.18 | 23.55 | |
| Research & Development | 220.26 | 186.8 | 172.13 | 123.19 | 75.97 | 53.6 | |
| Operating Expenses | 324.22 | 259.85 | 232.85 | 174.17 | 115.14 | 77.15 | |
| Operating Income | -324.22 | -259.85 | -232.85 | -174.17 | -115.14 | -77.15 | |
| Interest Expense | -7.97 | -7.89 | -6.66 | -4.16 | -2.22 | -3.06 | |
| Interest & Investment Income | 17.13 | 21.12 | 23.36 | 10.01 | 0.39 | 0.92 | |
| Currency Exchange Gain (Loss) | -0.22 | -0.2 | 0.77 | -5.68 | -1.1 | -0.7 | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.04 | 0.04 | |
| EBT Excluding Unusual Items | -315.27 | -246.83 | -215.39 | -174 | -118.04 | -79.96 | |
| Other Unusual Items | - | - | - | - | - | -0.91 | |
| Pretax Income | -315.27 | -246.83 | -215.39 | -174 | -118.04 | -80.87 | |
| Income Tax Expense | -0.42 | 0.47 | 0.41 | 0.29 | - | - | |
| Net Income | -314.85 | -247.3 | -215.79 | -174.28 | -118.04 | -80.87 | |
| Net Income to Common | -314.85 | -247.3 | -215.79 | -174.28 | -118.04 | -80.87 | |
| Shares Outstanding (Basic) | 92 | 81 | 67 | 58 | 52 | 46 | |
| Shares Outstanding (Diluted) | 92 | 81 | 67 | 58 | 52 | 46 | |
| Shares Change (YoY) | 22.99% | 21.02% | 14.36% | 11.49% | 12.89% | 34.99% | |
| EPS (Basic) | -3.44 | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 | |
| EPS (Diluted) | -3.44 | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 | |
| Free Cash Flow | -283.27 | -198.94 | -191.13 | -130.32 | -84.52 | -63.78 | |
| Free Cash Flow Per Share | -3.09 | -2.47 | -2.87 | -2.24 | -1.62 | -1.38 | |
| EBITDA | -318.88 | -253.92 | -227.77 | -171.72 | -113 | -75.44 | |
| D&A For EBITDA | 5.34 | 5.93 | 5.08 | 2.45 | 2.15 | 1.71 | |
| EBIT | -324.22 | -259.85 | -232.85 | -174.17 | -115.14 | -77.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.